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ABSTRACT
Background:Whereas conventional white cassava roots are devoid
of provitamin A, biofortified yellow varieties are naturally rich in
b-carotene, the primary provitamin A carotenoid.
Objective: We assessed the effect of consuming yellow cassava on
serum retinol concentration in Kenyan schoolchildren with marginal
vitamin A status.
Design:We randomly allocated 342 children aged 5–13 y to receive
daily, 6 d/wk, for 18.5 wk 1) white cassava and placebo supplement
(control group), 2) provitamin A–rich cassava (mean content: 1460
mg b-carotene/d) and placebo supplement (yellow cassava group),
and 3) white cassava and b-carotene supplement (1053 mg/d; b-carotene
supplement group). The primary outcome was serum retinol concen-
tration; prespecified secondary outcomes were hemoglobin concentra-
tion and serum concentrations of b-carotene, retinol-binding protein,
and prealbumin. Groups were compared by using ANCOVA, adjusting
for inflammation, baseline serum concentrations of retinol andb-carotene,
and stratified design.
Results: The baseline prevalence of serum retinol concentration
,0.7 mmol/L and inflammation was 27% and 24%, respectively. For
children in the control, yellow cassava, and b-carotene supplement
groups, the mean daily intake of cassava was 378, 371, and
378 g, respectively, and the total daily supply of provitamin A
and vitamin A from diet and supplements was equivalent to 22, 220,
and 175 mg retinol, respectively. Both yellow cassava and b-carotene
supplementation increased serum retinol concentration by 0.04 mmol/L
(95% CI: 0.00, 0.07 mmol/L); correspondingly, serum b-carotene con-
centration increased by 524% (448%, 608%) and 166% (134%, 202%).
We found no effect on hemoglobin concentration or serum concentra-
tions of retinol-binding protein and prealbumin.
Conclusions: In our study population, consumption of yellow cas-
sava led to modest gains in serum retinol concentration and a
large increase in b-carotene concentration. It can be an effica-
cious, new approach to improve vitamin A status. This study was
registered with clinicaltrials.gov as NCT01614483. Am J Clin Nutr
2016;103:258–67.
Keywords: biofortification, efficacy, food-based approach, nutri-
tion-sensitive intervention, vitamin A
INTRODUCTION
Biofortified yellow cassava has great potential to alleviate vi-
tamin A deficiency complementary to other interventions such as
vitamin A supplementation and fortification (1). Vitamin A de-
ficiency prevails in sub-Saharan Africa despite national supple-
mentation and food fortification programs, and 30% of preschool
children in developing countries have vitamin A deficiency (2).
Vitamin A supplementation in preschool children reduces all-cause
mortality by 24% (3). Considering the high prevalence of vitaminA
deficiency, even small increases in the supply of vitamin A through
biofortified crops are likely to result in major public health gains.
Cassava is an important staple food for many people in de-
veloping countries, particularly in sub-Saharan Africa, large parts
of Latin America, and Asia. The crop is well suited to arid and
semiarid areas and is grown even in remote areas by poor sub-
sistence farming families with the highest burden of vitamin A
deficiency. In many areas, children from such families are
difficult to reach through supplementation or fortification (1).
Because cassava is multiplied through vegetative propagation,
farmers can grow improved varieties indefinitely with marginal
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inputs (4). Most cassava varieties grown in Africa have white
roots with virtually no provitamin A. There are clones originating
in the Amazon basin with yellow roots due to the natural presence
of provitamin A. These yellow varieties have been crossbred with
African cassava varieties, by using conventional techniques, to
increase provitamin A content (5).
Yellow cassava contains provitamin A carotenoids primarily as
b-carotene, which humans absorb and convert to retinol (vita-
min A). Because of differences in the food matrix, this bio-
efficacy varies greatly between crops but is generally higher for
roots and tubers than for dark-green leafy vegetables (6). In
addition, conversion of b-carotene may depend on mutations in
the gene encoding for b-carotene 15,15#-monooxygenase (BCMO1),
the enzyme that converts b-carotene to retinol (7, 8). This conversion
is thought to depend on vitamin A status and to be more efficient in
deficiency (9, 10). Zinc deficiency can theoretically impair pro-
vitamin A bioefficacy because it is essential for transport and
metabolism of vitamin A (11).
Serum retinol concentration indicates population vitamin A
status and is a suitable marker to evaluate the impact of in-
terventions (12). Its distribution shifts only transiently (,2 mo)
by supplementation, but it is sustainably increased by regular
intake of vitamin A (13).
We aimed to assess the effect of consuming biofortified yellow
cassava on serum retinol concentration in Kenyan children with
mild to moderate vitamin A deficiency. In preplanned subgroup
analyses, we also explored effect modification by BCMO1 ge-
notype and for vitamin A and zinc status.
METHODS
Study design
The study was designed as a randomized controlled trial with 3
parallel arms with a daily intake, 6 d/wk, of 1) white cassava and
placebo supplement (control group), 2) provitamin A–rich cassava
and placebo supplement (yellow cassava group), or 3) white cas-
sava and b-carotene supplement (b-carotene supplement group).
The latter group was included as a positive control.
The study was registered (clinicaltrials.gov: NCT01614483)
and approved by ethical committees in Kenya and the Nether-
lands, with oversight by a data safety monitoring board. Written
consent was obtained from parents and children.
Subjects and screening
The study was conducted from May until November 2012 in 3
primary schools in Kibwezi District, Kenya. All children aged 5–
13 y with parental consent were invited for screening. Parents
were asked to not give foods to their child on the morning of the
screening visit. At this visit (Figure 1), we collected capillary
blood samples in a tube containing EDTA. We assessed hemo-
globin concentration and C-reactive protein concentration in
whole blood by point-of-care tests and Plasmodium infection in
whole blood by using dipstick tests. We stored plasma samples
in liquid nitrogen for subsequent measurement of plasma retinol-
binding protein concentration as a proxy for vitamin A status.
This measurement was done in the field, within 10 d after blood
collection. Children were excluded from further study when
having a 14-d parent-reported history of infectious or sys-
temic disease, Plasmodium infection, hemoglobin concentration
,70 g/L, or inflammation (C-reactive protein concentration .8
mg/L, the minimum detection level for the point-of-care test).
Of those remaining, we selected 360 children with the lowest
retinol-binding protein concentrations for further study, con-
sidering that intervention efficacy was likely to be inversely
associated with vitamin A status.
Run-in period
At the start of a 2-wk run-in period, these 360 children received
praziquantel (40 mg/kg body weight) and albendazole (100 mg,
single dose) against helminth infections. During the run-in pe-
riod, they were daily offered servings of boiled white cassava and
capsules with placebo supplements. At the end of the run-in
period (baseline), children were excluded when having missed
.20% of the feeding sessions or when having been unable to
consume$80% of their target portion of cassava (325 g and 375 g
for children 5–8 y and 9–13 y, respectively).
At the end of the run-in period, children were invited for
a second visit (baseline). Parents were asked to not give foods to
their child on the morning of this visit. Weight and height were
measured according toWHO guidelines (14) to the nearest 0.1 kg
and 0.1 cm by using a mechanical floor scale and a portable
stadiometer (Seca). We collected venous blood samples in a tube
without anticoagulant and suitable for trace element analysis
(Becton Dickinson) and in a tube with K2EDTA (Becton Dickinson).
We assessed hemoglobin concentration and C-reactive protein
concentration in whole blood by point-of-care tests and excluded
those with hemoglobin concentration ,70 g/L or inflammation
(C-reactive protein concentration .8 mg/L).
Randomization and blinding
Children were allocated by stratified block randomization,
after baseline data collection. Randomization was done by one of
the authors (HV) not involved in the field work, based on a list
with child names and corresponding plasma retinol-binding
protein concentrations measured before the run-in period. Tables
with random numbers were used to generate the allocation se-
quence consisting of random permuted blocks with size 6 or 9
within each of 3 strata, corresponding to tertiles of retinol-binding
protein concentration. The final allocation list contained each
child’s name and a group code letter A–C. Both the field team and
participants were unblinded to the type of cassava (white or
yellow) but were blinded to supplementation with b-carotene or
placebo supplements, which were formulated as opaque capsules.
Interventions and follow-up
White cassava and 7 different varieties of yellow cassava were
grown at a location close to the study site, with staggered planting
to allow roots to be harvested at 7–10 mo after planting. Yellow
cassava varieties had been screened and preselected based on
low cyanide concentration and suitability for freshly boiled
consumption and contained 4.7–6.9 mg/g total b-carotene (fresh
weight). Cyanide content was rechecked for each variety before
consumption as described elsewhere (15). The roots were har-
vested daily in the afternoon and prepared the subsequent
morning at each school; roots were peeled, chopped, rinsed, and
boiled for 1 h or until done. Cassava was drained, mashed with
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oil and salt as per standardized recipe, and served warm as
a midmorning snack, 6 d/wk for 18.5 wk. During feeding ses-
sions, intervention groups were physically separated at each
school and monitored to avoid food sharing and spilling. Target
portions were $325 g and $375 g for children aged 5–8 y and
9–13 y, respectively. The amount of cassava eaten was recorded
daily for each child as the difference in weight of the serving
before and after eating. At each school, interventions started for
all children simultaneously, 2 d after the run-in period.
Supplemental capsules contained either 1053 mg b-carotene
(Betatap 20%S; DSM Nutritional Products) or no active in-
gredient (placebo), with starch as filler. Capsules were admin-
istered directly after feeding and were swallowed with water
under supervision. Portions (375 g) of cooked white and yellow
cassava were sampled daily at each school and mixed with a food
processor after the addition of the preservative antioxidant
tert-butylhydroquinone (2.5 mL/kg) dissolved in methanol
(20 g/100 mL). Duplicate samples (15 g/d) were pooled by
week per school and stored at 2158C in Kenya, transported,
and stored at 2808C in the Netherlands.
On completion of the intervention period, we repeated blood
and data collection by using the same procedures as at baseline,
except that the trace element tube was replaced by a serum
separation tube (Becton Dickinson). Whole blood was stored in
DNA-stabilizing buffer (AS1; Qiagen) and kept at 48C during
transport to the Netherlands until DNA analysis. Serum samples
were shielded from light, processed under subdued light con-
ditions, and kept in amber cryovials at 21968C in the field and
2808C during transport and storage until assessment of retinol
concentrations in the Netherlands. For ethical reasons, all children
received a supplement with vitamin A (100,000 IU) on completion
of the intervention. In addition to the experimental cassava, we
FIGURE 1 Flow of participants. 1The upper segment of retinol-binding protein concentrations were not eligible for run-in and were excluded. 2Children
who could not consume 80% of their respective portion size were excluded.
260 TALSMA ET AL.
provided daily voluntary lunches with cooked maize and beans for
all schoolchildren.
24-h recall data
At 13–16 wk after randomization, mean daily intake of en-
ergy, fat, and vitamin A was measured in 334 subjects by
quantitative 24-h recall and repeated in a subsample (n = 101) on
nonconsecutive days (see Online Supplemental Material).
Biochemical analyses
For screening, we assessed the indicators in the field as fol-
lows: 1) hemoglobin concentration by photometer (Hemocue
201+, HemoCue), 2) whole-blood C-reactive protein concen-
tration by immunoturbidimetric assay (QuikRead; Orion Di-
agnostica), 3) plasma retinol-binding protein concentrations
in duplicate by ELISA (K-assay KT-504; Kamiya Biomedical
Company) with an iMark microplate absorbance reader (Bio-
Rad Laboratories; intra-assay CV: 2.4%, interplate CV: 1.5%
in 32 plates), and 4) Plasmodium infection in whole blood by
using dipstick tests specific for P. falciparum histidine-rich
protein-2 and lactate dehydrogenase specific to either Plasmodium
falciparum or non-falciparum human Plasmodium species
(CareStart G0121 and G0171; AccessBio).
The remainder of this section describes measurements at
baseline and at the end of intervention.
Hemoglobin concentration
This was measured within 6 h after blood collection by using
a hematology analyzer (Celltac-a, MEK-6410K; Nihon Kohden).
Serum concentrations of retinol and b-carotene
Serum collected at baseline and end of intervention was an-
alyzed (May 2013) in pairs to reduce analytic variation. Con-
centrations of retinol and carotenoids were measured by HPLC
(Thermo Scientific Accela LC system; Thermo Fisher Scientific)
and analyzed by using EZChrom Elite version 3.2.2 SP2 software
(Agilent Technologies). In total, 500 mL serum, 500 mL NaCl
(0.9 w/v% in water), and 1000 mL ethanol (with added retinyl
acetate as internal standard) were mixed and extracted twice
with 30 mL hexane. The hexane layers were pooled and evap-
orated to dryness in a vacuum concentrator at 358C (RVC 2.25
CD plus; MartinChrist). The residue was dissolved in a 250-mL
mixture of methanol and butanol (60:40 vol:vol %); 15 mL was
injected per HPLC analysis. Sample preparations were done
under subdued yellow light. Retinol, retinyl acetate, lutein,
zeaxanthin, b-cryptoxanthin, a-carotene, b-carotene, and lyco-
pene were separated on a C18 reversed phase column (Vydac
201TP52, Grace, Columbia, Maryland, USA) by using gradient
elution and monitored at 325 nm (retinol and retinyl acetate) and
450 nm (carotenoids) on a photodiode array detector. Runtime
was 25 min per sample. Within- and between-run CVs for high
and low controls were 3.1% and 2.7% for retinol (concentration
w60 mg/100 mL), and 9.4% and 11.1% for b-carotene (con-
centration w10 mg/100 mL).
Serum retinol-binding protein concentration
For serum samples collected at the end of intervention, retinol-
binding protein concentrations were determined by ELISA
(Quantikine DRB400; R&D Systems). Results were read in
duplicate for 10% of samples. Interplate CV for 5 plates was
5.4%, and intra-assay CV was 2.9%.
Iron and inflammation markers in serum
Iron markers (concentrations of ferritin, soluble transferrin re-
ceptor) and inflammation markers (concentrations of C-reactive
protein and a1-acid glycoprotein), prealbumin concentration, and
zinc concentration were measured at the Meander Medical
Hospital (Amersfoort, Netherlands) on a Beckman Coulter
UniCel DxC 880i analyzer according to manufacturer’s in-
structions, with external reagents and standards to allow
measurement of zinc concentrations (DiaLab GmBH, cata-
log number 507240 Zinc, 5-Br-PAPS, and 507263SV Zinc
Standard).
DNA sequence variants
By using a candidate gene approach, we assessed allele variants
on 5 loci in the BCMO1 gene that had previously been shown to
be associated with a decreased conversion of b-carotene to ret-
inol (7, 8)—namely, rs12934922 (R267S), rs7501331 (A379V),
rs11645428, rs6564851, and rs6420424. DNAwas isolated from
whole-blood samples (FADWE002, Favorgen Biotech Cor-
poration Ping Tung, Taiwan), and the designated allele vari-
ants of the BCMO1 gene were scored from 0 to 1 by using
the Assay Design Tool (Illumina Technical Support) based
on compatibility to successful GoldenGate genotyping. Se-
quence variants with a score .0.4 were genotyped by Il-
lumina’s VeraCode GoldenGate Genotyping Assay on a
BeadXpressplatform by using the VeraCode technology.
Sequence variants clustering was also assessed visually to de-
termine success of genotyping. Sequence variants with a Gen-
Call score .0.5 and a call rate $0.90 were included in the final
analysis. Of 5 sequence variants analyzed, one (rs12934922)
yielded no detectable signal and was excluded for analysis. For
several children, DNA qualities were low, resulting in 56–88
children being excluded depending on the sequence variant
investigated.
Total b-carotene concentration in cassava
Carotenoids from either raw or cooked cassava were analyzed
by using the same HPLC system as described above for serum
samples. To extract carotenoids cassava, we mixed 2 g ho-
mogenized cassava, 0.2 g magnesium carbonate, 5 mL deionized
water, and 1000 mL ethanol (with added retinyl acetate as in-
ternal standard) and extracted 3 times with 20 mL methanol-
tetrahydrofuran (1:1 vol:vol%) by using a rod mixer (Polytron
PT 20 OD; Kriens/Luzern) until the residue was colorless. Ex-
tracts were filtered on a glass funnel with filter paper (Whatman
grade 1, GE healthcare life Sciences); the combined filtrates
were transferred to a 50-mL volumetric flask and made up to
volume with methanoltetrahydrofuran (1:1 vol:vol%). Then,
4 mL filtrate with 1 mL 10% NaCl solution was transferred to
a 10-mL glass stoppered centrifuge tubes (Kimax, Kimble
Chase), and carotenoids were extracted 3 times with 1.5 mL
petroleum-ether containing 0.01% butylated hydroxytoluene.
The combined ether fractions were evaporated under nitrogen at
358C. The residue was dissolved in 2 mL methanol/butanol
(60/40 vol:vol%), and 1 mL was injected into the HPLC
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system. Carotenoids were separated on a Vydac 201TP52
column by using gradient elution and monitored at 450 nm on
a photodiode array detector. Runtime was 20 min per sample. We
measured the summed content of all forms of b-carotene, the
predominant provitamin A carotenoid in yellow cassava (16).
Within- and between-run CVs for high and low control for
b-carotene were 3.9% and 7.7% (concentrationw470 mg/100 g).
Statistics
Data were analyzed by using SPSS software, version 20 (SPSS
Inc.). For data analysis, we used markers measured in samples
collected at baseline and at the end of intervention. For C-reactive
protein, this resulted in different cutoff levels (.5 mg/L) to
define inflammation than used at screening. Inflammation
was also defined by serum a1-acid glycoprotein protein
TABLE 1
Baseline characteristics, by intervention group (per protocol analysis)1
Characteristic Control (n = 113)
Yellow cassava
(n = 109)
b-carotene
supplement
(n = 113)
Vital and personal characteristics
Age, y 8.9 6 2.12 8.8 6 2.4 8.9 6 2.4
Sex, F, n (%) 52 (46) 55 (50) 58 (51)
BMI-for-age z score, SD 21.4 6 0.9 21.5 6 0.9 21.5 6 0.9
Height-for-age z score, SD 21.2 6 1.2 21.1 6 1.1 21.3 6 1.0
Children being stunted, n (%) 24 (21) 22 (20) 22 (20)
Serum inflammation markers
C-reactive protein concentration, mg/L 0 (0, 0)3 0 (0, 0) 0 (0, 0)
a1-acid glycoprotein protein concentration, g/L 0.87 6 0.26 0.87 6 0.23 0.86 6 0.20
C-reactive protein concentration .5 mg/L, n (%) 3 (2.7) 4 (3.7) 1 (0.9)
C-reactive protein concentration .5 mg/L or a1-acid
glycoprotein concentration .1 g/L, n (%)
29 (26) 25 (23) 24 (21)
Serum vitamin A markers, all children
b-carotene concentration, mmol/L 0.34 (0.24, 0.48) 0.35 (0.24, 0.56) 0.35 (0.24, 0.48)
Retinol concentration, mmol/L 0.80 6 0.17 0.83 6 0.17 0.82 6 0.18
Prealbumin concentration, g/L 0.18 6 0.03 0.19 6 0.03 0.18 6 0.03
Vitamin A status
Deficient (retinol concentration ,0.70 mmol/L),
n (%)
31 (27) 29 (27) 30 (27)
Marginal (retinol concentration 0.70–1.05 mmol/L),
n (%)
72 (64) 71 (65) 75 (66)
Serum vitamin A markers, children without inflammation
Retinol concentration, mmol/L 0.82 6 0.17 0.84 6 0.17 0.83 6 0.17
Vitamin A status
Deficient (retinol concentration ,0.70 mmol/L),
n (%)
20 (24) 20 (24) 20 (22)
Marginal (retinol concentration 0.70–1.05 mmol/L),
n (%)
54 (64) 57 (68) 63 (72)
Serum zinc markers, all children
Zinc concentration, mmol/L 13.5 6 2.3 14.3 6 2.0 14.0 6 2.3
Deficient (zinc concentration ,9.9 mmol/L), n (%) 4 (4) 1 (1) 3 (3)
Serum zinc markers, children without inflammation
Zinc concentration, mmol/L 13.1 6 2.3 14.2 6 1.8 14.0 6 2.2
Deficient (zinc concentration ,9.9 mmol/L), n (%) 4 (5) 1 (1) 3 (4)
Iron markers, all children
Hemoglobin concentration, g/L 131 6 10 130 6 12 132 6 12
Serum ferritin concentration, mg/L 18.4 (11.4, 24.2) 17.8 (11.2, 25.6) 15.6 (10.4, 24.4)
Serum soluble transferrin receptor concentration, mg/L 1.72 (1.51, 2.05) 1.83 (1.60, 2.12) 1.86 (1.62, 2.17)
Anemia, n (%) 8 (7) 8 (7) 7 (6)
Iron deficiency, n (%) 33 (29) 44 (40) 48 (43)
Iron deficiency anemia, n (%) 6 (5) 7 (6) 5 (4)
Iron markers, without inflammation
Serum ferritin concentration, mg/L 17.1 (10.8, 22.3) 17.5 (11.4, 24.5) 15.4 (10.1, 23.0)
Iron deficiency, n (%) 26 (31) 33 (39) 37 (42)
Iron deficiency anemia, n (%) 5 (6) 4 (5) 4 (5)
1Inflammation was defined as serum C-reactive protein concentrations .5 mg/L and/or serum a1-acid glycoprotein
concentration .1 g/L. Anemia was defined as a hemoglobin concentration ,115 g/L or ,120 g/L for children aged 5–11 y
and .12 y, respectively. Iron deficiency was defined as a serum ferritin concentration ,15 mg/L and soluble transferrin
receptor concentration .1.55 mg/L. Iron deficiency anemia denotes iron deficiency with concurrent anemia.
2Mean 6 SD (all such values).
3Median; 25th, 75th percentiles in parentheses (all such values).
262 TALSMA ET AL.
concentration .1 g/L (17). Other cutoff levels were as follows:
vitamin A deficiency, serum retinol concentration ,0.7 mmol/L
(18); zinc deficiency, serum zinc concentration ,9.9 mmol/L
(19); anemia, hemoglobin concentration ,115 g/L and ,120 g/L
for children aged 5‒11 y and 12‒13 y, respectively (20); and
iron deficiency, serum ferritin concentration ,15 mg/L (20) and
serum soluble transferrin receptor concentration .1.55 mg/L
(21). Compliance with treatment was computed as the percent-
age of the age-specific target amount of cassava consumed for
the total duration of the intervention.
Our preplanned primary outcome was serum retinol con-
centration at the end of intervention; secondary outcomes were
serum concentrations of total b-carotene, retinol-binding pro-
tein, prealbumin, and hemoglobin concentration. Distributions
of dependent variables were checked for normality and log-
transformed for serum b-carotene concentration. As preplanned,
the primary analysis was per protocol and restricted to children
who attended .80% of intervention days and consumed .80%
of the target amount of cassava over the total intervention pe-
riod. For primary and secondary analyses, we used ANCOVA to
compare intervention groups, adjusting for the stratified design,
serum concentrations at baseline of C-reactive protein, a1-acid
glycoprotein, retinol, and zinc; sex; and anemia. In the crude
analysis, we adjusted only for the stratified design; for the ad-
justed analysis, covariates (serum concentrations at baseline of
C-reactive protein, a1-acid glycoprotein, and zinc; sex; and
anemia) were eliminated by using a backward elimination pro-
cedure (22) from the model when their exclusion affected the
magnitude of the intervention effect by ,10%. In the adjusted
analysis of each outcome, we also adjusted for the same marker
measured at baseline (e.g., in the analysis of serum retinol
concentration, we adjusted for serum retinol concentration at
baseline) except for serum retinol-binding protein concentration
(not measured at baseline). In the analysis of serum concentrations
of retinol and retinol binding protein, we also adjusted for serum
concentrations of C-reactive protein and a1-acid glycoprotein at
the end survey to eliminate possible effects of inflammation. Se-
rum b-carotene concentration was log-transformed, both as out-
come and as covariate measured at baseline. To express results for
serum b-carotene concentration in natural units, we exponentiated
log-transformed estimates of intervention effects and expressed
them as percentages.
We assessed effect modification by baseline vitamin A and
zinc status by using stratified analyses and directly by evaluating
product terms of intervention with zinc deficiency, vitamin A
status, and sequence variants of DNA in multiple linear re-
gression analyses. When analyzing effect modification by se-
quence variants of DNA, we combined the groups receiving yellow
cassava and b-carotene supplements to increase the sample size
for each genotype.
We based the statistical power of this trial on a mean 6 SD
expected treatment effect of 0.096 0.19 mmol/L (23); with 80%
power and a 2-sided significance of 0.05, we needed 105 chil-
dren per group, allowing a 10% dropout rate.
RESULTS
Of 1256 screened children, 342 (27%) were randomly allo-
cated. Exclusions were mostly because we selected for children
with low plasma concentrations of retinol-binding protein. Four
children were lost to follow-up, 1 child did not have a baseline
sample, and 2 children did not meet compliance criteria, resulting
in 335 children in the per protocol analyses (Figure 1).
Baseline serum retinol concentrations indicated a study
population with marginal vitamin A status (Table 1). One-fourth
of children had inflammation as indicated by elevated concen-
trations of C-reactive protein, a1-acid glycoprotein, or both.
When these children were excluded from the analysis, one-
fourth were vitamin A deficient.
Compliance with the cassava feeding was 100% with mean
portion sizes of 336 g and 382 g for children aged 5–8 y and 9–13 y,
respectively (Table 2). The mean daily intake of vitamin A
TABLE 2
Daily intake of energy, fat, vitamin A, and b-carotene from diet and intervention
Control (n = 113) Yellow cassava (n = 109)
b-carotene supplement
(n = 113)
General diet (excluding experimental cassava)1
Energy, kJ 5739 (4175, 8049)2 5673 (4605, 6988) 5863 (4391, 7929)
Fat, % energy 13.1 (11.3, 16.6) 14.1 (12.3, 16.9) 14.0 (12.0, 15.9)
Vitamin A intake,3 mg RAE4 16.9 (4.6, 38.6) 13.8 (4.0, 46.1) 21.1 (9.5, 40.5)
Children without any preformed retinol, n (%) 86 (77) 83 (76) 74 (65)
Supplied by intervention
Amount of cassava eaten daily,5 g 378 (339, 383) 371 (333, 381) 378 (340, 384)
b-carotene from cassava,6 mg 38 (34, 39) 1463 (1313, 1501) 38 (34, 39)
b-carotene from supplement, mg 0 0 1053 (1044, 1053)
Vitamin A supplied by general diet and intervention, mg
RAE6,7
22 (10, 44) 220 (205, 241) 175 (164, 195)
1Based on 24-h recall data with n = 111 in the control group, n = 108 in the yellow cassava group, and n = 113 in the b-carotene supplement group.
2Median; 25th, 75th percentiles in parentheses (all such values).
3Assuming that 12 mg b-carotene from a mixed diet is absorbed and converted to 1 mg retinol.
4RAE, retinol activity equivalent.
5Cassava was cooked in water for 1 h, any leftover water was discarded, and the cassava was mashed with 12 g oil and 8 g salt/kg cooked cassava.
6Based on mean 6 SD b-carotene concentrations of 3.94 6 0.75 mg/g (range: 3.04–5.44 mg/g) (fresh weight) and 0.10 6 0.03 mg/g
(range: 0.04–0.15 mg/g) for boiled yellow and white cassava, respectively.
7Assuming that 7 mg b-carotene supplement or cassava is absorbed and converted to 1 mg retinol.
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from the general diet was low at w20 mg retinol activity
equivalents in all groups. The mean 6 SD of weekly pooled
samples of total b-carotene content in boiled yellow cassava
was 3.94 6 0.75 mg/g (range: 3.04–5.44 mg/g). The total ret-
inol activity equivalent intakes were 22 mg, 220 mg, and 175 mg
in the groups receiving control, yellow cassava, and b-carotene
supplements, respectively. We found no Plasmodium infection at
the end of intervention.
In the primary analysis, both consumption of yellow cassava
and supplementation with b-carotene increased serum retinol
concentration by 0.04 mmol/L (Table 3). Intention-to-treat
analyses showed similar effects (not shown). Correspondingly,
consumption of yellow cassava and supplementation with
b-carotene increased serum b-carotene concentration by 524%
and 166%, respectively. There were no marked effects of yellow
cassava and b-carotene supplementation on the prevalence of
vitamin A deficiency. We found no evidence that interventions
changed serum concentrations of retinol-binding protein or
prealbumin or hemoglobin concentration. Intervention estimates
with and without adjustment for inflammation markers at the
end survey were similar (not shown).
There was no evidence that intervention effects varied by
initial vitamin A status or initial zinc status (Figure 2A) or
BCMO1 genotype (Figure 2B). For rs7501331, all children ex-
cept for one were wild type. Minor allele frequencies were 0.09
for rs11645428, 0.60 for rs6564851, and 0.56 for rs6420424, and
there was no evidence that any allele variants except rs7501331
were in Hardy-Weinberg disequilibrium, which indicates that
these variants do not pose strong selective pressure on the study
population.
DISCUSSION
Daily consumption of yellow cassava resulted in modest in-
creases in serum retinol concentration and large increases in
b-carotene concentration compared with control, showing that
b-carotene was well absorbed. There was no evidence that the
effect on serum retinol concentration depended on initial vitamin
TABLE 3
Effect of consumption of yellow cassava and supplementation with b-carotene on various outcomes1
Outcome/intervention group n Estimate
Intervention effect
Crude2 (95% CI) Adjusted3 (95% CI)
Serum retinol concentration, mmol/L
Control 113 0.77 6 0.014 Reference Reference
Yellow cassava 109 0.81 6 0.01 0.05 (0.01, 0.10) 0.04 (0.00, 0.07)
b-carotene supplement 113 0.81 6 0.01 0.05 (0.00, 0.09) 0.04 (0.00, 0.07)
Prevalence of vitamin A deficiency,5 n (%)
Control 113 34 (30.1) Reference NA
Yellow cassava 109 29 (26.6) 23.5% (215.1%, 8.3%) NA
b-carotene supplement 113 33 (29.2) 20.9% (214.9%, 9.1%) NA
Serum b-carotene concentration, mmol/L
Control 113 0.426 Reference Reference
Yellow cassava 109 0.946 537% (453%, 633%) 524% (448%, 608%)
b-carotene supplement 112 0.656 164% (130%, 203%) 166% (134%, 202%)
Serum retinol-binding protein concentration,
mmol/L
Control 112 0.62 6 0.01 Reference Reference
Yellow cassava 108 0.62 6 0.01 0 (20.04, 0.04) 0 (20.04, 0.04)
b-carotene supplement 113 0.65 6 0.01 0.03 (20.01, 0.07) 0.03 (20.01, 0.07)
Serum prealbumin concentration, g/L
Control 113 0.18 6 0.00 Reference Reference
Yellow cassava 108 0.18 6 0.00 0 (20.01, 0.01) 0 (20.01, 0.01)
b-carotene supplement 111 0.18 6 0.00 0 (20.01, 0.01) 0 (20.01, 0.01)
Hemoglobin concentration, g/L
Control 112 130.6 6 0.7 Reference Reference
Yellow cassava 109 130.4 6 0.7 20.3 (23.1, 2.5) 0.0 (22.8, 2.7)
b-carotene supplement 112 129.9 6 0.7 20.2 (22.1, 1.8) 20.7 (22.6, 1.2)
1Intervention groups were compared by using ANCOVA (see text). NA, not applicable.
2Adjusted for stratified design only.
3In the analysis of each outcome, we also adjusted for the same marker measured at baseline (e.g., in the analysis of
serum retinol concentration, we adjusted for serum retinol concentration at baseline) except for serum retinol-binding
protein concentration (not measured at baseline). In the analysis of serum retinol concentration and serum retinol binding
protein concentration, we also adjusted for serum concentrations of C-reactive protein and a1-acid glycoprotein measured at
the end of intervention. Serum b-carotene concentration was log-transformed, both as outcome and as covariate measured
at baseline. To express results for serum b-carotene concentration in natural units, we exponentiated log-transformed
estimates of intervention effects and expressed them as percentages.
4Mean 6 SE (all such values).
5Serum retinol concentration ,0.7 mmol/L.
6Geometric mean.
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A status, zinc status, or BCMO1 genotype. Similar effects were
obtained with b-carotene supplementation.
To our knowledge, this is the first randomized trial with yellow
cassava in a target population where vitamin A deficiency is
prevalent. Attrition was low, with only 4 children lost to follow-up,
and compliance with feeding was high, with almost all children
consuming more than their assigned portions sizes and only 2
children failing to finish their rations on a daily basis.
Serum retinol concentration, our primary outcome, is recom-
mended by the WHO to assess population vitamin A status and to
evaluate the effect of interventions (12). Serum retinol concen-
tration reflects liver vitamin A stores in the range ,0.07 mmol/g
liver (20 mg/g), which corresponds to serum retinol concentra-
tion ,1.75 mmol/L (50 mg/dL) (24). At baseline, all children in
our study were within this range. Approximately one-fourth
had serum retinol concentrations ,0.70 mmol/L (20 mg/dL),
indicating deficiency, and only 8% had serum retinol concen-
trations .1.05 mmol/L (30 mg/dL) (Table 1), the cutoff that
corresponds to mean concentrations in most well-nourished
populations with “adequate” stores (12).
We expected to find a larger intervention effect of yellow
cassava or b-carotene supplementation on serum retinol con-
centration, particularly in the subgroup of children with vitamin
A deficiency. The large increase in serum b-carotene concen-
tration and modest increase in serum retinol concentration in our
study reflect poor bioconversion of b-carotene to retinol. Zinc
deficiency has been suggested to reduce enzymatic cleavage of
b-carotene (25), but we could not draw conclusions on its in-
fluence on the effect of interventions because it occurred in only
4 children in our study.
Similar to our study, daily consumption of biofortified sweet
potato in South African children and Bangladeshi women resulted
FIGURE 2 Effect of yellow cassava (A) and increased intake of b-carotene (B) on serum retinol concentration, by subgroups. *Adjusted means 6 SEs.
Normal genotypes are displayed on top. In the analyses of serum retinol concentration, we adjusted for the stratified design, serum retinol concentration at
baseline, and concentrations of serum C-reactive protein and a1-acid glycoprotein at the end of intervention.
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in large increases in serum b-carotene concentration but no evi-
dent effect on serum retinol concentration (26, 27). In other trials,
provitamin A–rich vegetables and fruits resulted in larger effects
on serum retinol concentration than in our study, but vitamin A
deficiency persisted in a substantial proportion of study partici-
pants despite large effects on b-carotene concentrations (23, 28).
Could poor bioconversion be due to genetic factors? A specific
allelic variant (rs7501331; A379V) within the BCMO1 coding
region is common in Caucasians and was found to reduce
b-carotene conversion by 32% (8). Our study participants,
however, were nearly all homozygous wild type for this allelic
variant. We found no evidence for effect modification by any of
the other allelic variants investigated. It should be noted, how-
ever, that subgroup analysis may be limited by sample size,
which is often inadequate to provide adequate statistical support
for effect modification (29), which might have been the reason
we did not find evidence. Subjects with wild type for
rs11645428 seemed to have a lower response to intervention
than heterozygous subjects. This finding is in agreement with
a reduction of 51% in b-carotene conversion reported by others
(7). Whether this variant or as yet unidentified variants in the
BCMO1 gene may explain the low b-carotene conversion found
in this African study population needs further elucidation.
The question arises whether the sharp increase in serum
b-carotene concentration in our trial and similar studies has
functional significance. Circulating b-carotene is taken up and
concentrated in various tissues (30) such as liver and adipose
tissues, whereas kidney and lung tissues have minor roles for
storage (31). In steady state, only 1% of the total body content of
carotenoids is contained in serum (6). Studies have shown that
BCMO1 is expressed not only in enterocytes but also in various
cell types in a broad variety of human tissues, including liver
tissue (32, 33). This could indicate that these tissues have the
capacity to convert circulating or locally stored carotenoids on
need. The hypothesis that conversion into vitamin A takes place
in tissues and not only in the intestine (31) would explain the
efficacy of orally dosed b-carotene in reducing manifestations of
vitamin A deficiency as shown in several trials (34–36). If so,
b-carotene in tissues may function as a store. This would need
a reconsideration of the definition of vitamin A deficiency,
which is currently based on liver retinol stores only. Thus,
evaluation by serum retinol concentration [or its proxy markers
serum concentration of prealbumin and retinol-binding protein
(37)] may well overestimate the prevalence of deficiency in
surveys and underestimate the true impact of interventions based
on plant foods.
Our study was conducted in primary schoolchildren who are at
lower risk of vitamin A deficiency than preschool children (2, 12).
We selected older children to reduce possible interference with
the national vitamin A supplementation program for children
6–59 mo of age; to achieve higher intake of cassava and
b-carotene, because older children are able to consume more
food; and to simplify logistics of the trial because the school
setting enabled us to optimize supervision and compliance. In-
terventions with yellow cassava may have similar or even
a larger impact in younger children because they are bound to be
more vitamin A deficient, especially in areas where vitamin A
supplementation programs are poorly implemented.
We used yellow varieties that were still below the breeding
target concentrations of 15 mg/g for cassava (38). Cassava
breeding is an ongoing, rapidly progressing process, and new
varieties with higher concentrations will become available in the
near future and will have a larger impact on vitamin A status
than we have shown here. Acceptance of the crop does not seem
to pose any difficulties as evidenced by a consumer acceptability
study in our research area (39).
Thus, in our population of children with marginal vitamin A
status without concurrent infection, consumption of yellow
cassava led to modest gains in serum retinol concentration and
a large increase in b-carotene concentration.
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